TrialBMC cancer2016

ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286).

Jens Hoeppner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.